TESTIMONIALS

Prof. Santiago Horgan

"I truly feel that this one, of all the endoscopic devices out there, is the one that has most of the potential to be very successful." (January 23, 2013)



Read more...

Prof. Jeff Peters

"The images look great in my opinion! Looks like a fundoplication in both cases"

Prof. Hubert Stein

"...there is no difference in the endoscopic image between a laparoscopic and an endoscopic anterior fundoplication. I couldn't tell which is which from the image"

Prof. David Watson

Performed the first clinical trials with the Medigus SRS device in Aug. 2006. In a report provided to Medigus regarding the procedures performed, Prof.
Watson stated when the stapling of the tissue is performed in a suitable position, the potential clinical results of the SRS procedure are excellent, with better short term outcome than would be expected following a standard laparoscopic Funduplication.

Dr. Amol Bapaye

"It seems to me that the Medigus SRS device is a landmark development in the management of GERD patients. The preliminary results of the procedure are very encouraging."
Medigus

Medigus is a medical device company specializing in developing innovative endoscopic procedures and devices, including the revolutionary disposable endoscope for the treatment of GERD (Gastroesophageal Reflux Disease).

The company, which was founded in January 2000, is based in Israel and is publicly traded on the TASE. Medigus owns a unique and outstanding technological platform enabling the company to bring into the world state-of-the-art medical device products.

Read more

News

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Prev Next

EAES European Association for Endoscopic Surgery

21-05-2013

June 19-22, 2013
Vienna, Austria
Visit us at booth #25

Read more

Successful Three-Year Follow-Up Data of the SRS™ Pivotal Study in Indiana University Will be Presented at the Digestive Disease Week in Orlando

16-05-2013

Medigus Ltd. (MDGS.TA), a leading medical device company dedicated to the development of innovative endoscopic procedures and technologies, will be presenting the successful three year follow-up da...

Read more

DDW Digestive Disease Week

06-05-2013

May 18-21, 2013
Orlando, Florida

Read more

Successful five-year follow-up data from SRS™ pilot study

05-05-2013

Medigus (TASE:MDGS) announced today that it had received five-year follow-up results of a pilot study of its SRS™ endoscopic system for the treatment of Gastroesophageal Reflux Disease (GERD). The ...

Read more

Medigus Signed a Distribution Agreement in China

12-03-2013

Local distributor to purchase SRS™II systems for a minimum of $3.85 million.

Read more

Medigus completed $8M private placement by OrbiMed

04-03-2013

Medigus (TASE:MDGS) announces that it had closed an $8 million investment by OrbiMed Israel Partners LP. Upon the closing of the investment, Dr. Nissim Darvish, senior managing director at OrbiMed ...

Read more

Columbia Medical Center Offers SRS Procedures

13-02-2013

Medigus (TASE:MDGS) announces that Columbia University Medical Center, Department of Surgery (New-York, New-York), now offers the SRS™ procedure for transoral incisionless treatment of GERD.

Read more

Medigus announces an exclusive distribution agreement for the SRS™II in Turkey

16-01-2013

Medigus (TASE:MDGS) announces an exclusive distribution agreement for the SRS™II in Turkey.

Read more